<button id="eiezk"><video id="eiezk"></video></button>

產品名稱

Homocamptothecin, (±)-E- - hCPT, dl- | BN 80245

產品貨號

Axon 1687 CAS [186668-40-6] MF C21H18N2O4MW 362.38 Purity: 99% Optical purity: racemate Moderately soluble in DMSO Description A potent topoisomerase I (Topo 1) inhibitor; Homocamptothecin (hCPT) is an E-ring modified analogue of camptothecin (CPT), with enhanced stability and potent Topo-1 mediated activity; apoptosis agent References Certificates Categories Extra info L Lesueur-Ginot et al. Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties. Cancer Res. 1999, 59(12), 2939-2943. ? O Lavergne et al. Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues. J. Med. Chem. 1998, 41(27), 5410–5419. Certificate of Analysis Material Safety Data Sheet Apoptosis Cell Signaling & Oncology DNA-damage Response EC 5.99.1.2 TOPO Potent topoisomerase I (Topo 1) inhibitor Chemical name 3H,15H-Oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione, 5-ethyl-1,4,5,13-tetrahydro-5-hydroxy- Parent CAS No. [186668-40-6] Order Size Unit Price Stock 5 mg €135.00 In Stock

產品價格

現貨詢價，電話：010-67529703

產品規(guī)格

產品品牌

axonmedchem

產品概述

產品詳情

Homocamptothecin, (±)-E- - hCPT, dl- | BN 80245

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 1687

CAS [186668-40-6]

MF C21H18N2O4
MW 362.38

Purity: 99%
Optical purity: racemate
Moderately soluble in DMSO

Homocamptothecin, (±)-E-

Description

A potent topoisomerase I (Topo 1) inhibitor; Homocamptothecin (hCPT) is an E-ring modified analogue of camptothecin (CPT), with enhanced stability and potent Topo-1 mediated activity; apoptosis agent

L Lesueur-Ginot et al. Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties. Cancer Res. 1999, 59(12), 2939-2943.

O Lavergne et al. Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues. J. Med. Chem. 1998, 41(27), 5410–5419.

Certificate of Analysis
Material Safety Data Sheet

Apoptosis Cell Signaling & Oncology DNA-damage Response EC 5.99.1.2 TOPO

Potent topoisomerase I (Topo 1) inhibitor

Chemical name

3H,15H-Oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione, 5-ethyl-1,4,5,13-tetrahydro-5-hydroxy-

Parent CAS No.

[186668-40-6]

產品資料

<button id="eiezk"><video id="eiezk"></video></button>